|
1
|
Anandamide inhibits metabolism and physiological actions of 2-arachidonoylglycerol in the striatum.
|
Nat Neurosci
|
2008
|
2.87
|
|
2
|
A substrate trapping mutant form of striatal-enriched protein tyrosine phosphatase prevents amphetamine-induced stereotypies and long-term potentiation in the striatum.
|
Biol Psychiatry
|
2008
|
1.63
|
|
3
|
Abnormal striatal GABA transmission in the mouse model for the fragile X syndrome.
|
Biol Psychiatry
|
2007
|
1.48
|
|
4
|
The GTP-binding protein Rhes modulates dopamine signalling in striatal medium spiny neurons.
|
Mol Cell Neurosci
|
2007
|
1.33
|
|
5
|
TRPV1 channels facilitate glutamate transmission in the striatum.
|
Mol Cell Neurosci
|
2008
|
1.08
|
|
6
|
The endocannabinoid system is dysregulated in multiple sclerosis and in experimental autoimmune encephalomyelitis.
|
Brain
|
2007
|
1.01
|
|
7
|
Abnormal sensitivity to cannabinoid receptor stimulation might contribute to altered gamma-aminobutyric acid transmission in the striatum of R6/2 Huntington's disease mice.
|
Biol Psychiatry
|
2005
|
0.92
|
|
8
|
Multiple mechanisms underlying the neuroprotective effects of antiepileptic drugs against in vitro ischemia.
|
Stroke
|
2006
|
0.91
|
|
9
|
The brain cytoplasmic RNA BC1 regulates dopamine D2 receptor-mediated transmission in the striatum.
|
J Neurosci
|
2007
|
0.88
|
|
10
|
Chronic cocaine prevents depotentiation at corticostriatal synapses.
|
Biol Psychiatry
|
2006
|
0.87
|
|
11
|
Chronic cocaine sensitizes striatal GABAergic synapses to the stimulation of cannabinoid CB1 receptors.
|
Eur J Neurosci
|
2007
|
0.86
|
|
12
|
Deficits of glutamate transmission in the striatum of toxic and genetic models of Huntington's disease.
|
Neurosci Lett
|
2006
|
0.86
|
|
13
|
Endocannabinoids limit metabotropic glutamate 5 receptor-mediated synaptic inhibition of striatal principal neurons.
|
Mol Cell Neurosci
|
2007
|
0.85
|
|
14
|
Synaptic plasticity during recovery from permanent occlusion of the middle cerebral artery.
|
Neurobiol Dis
|
2007
|
0.84
|
|
15
|
Cerebrospinal fluid levels of the endocannabinoid anandamide are reduced in patients with untreated newly diagnosed temporal lobe epilepsy.
|
Epilepsia
|
2009
|
0.84
|
|
16
|
Cerebellar control of cortico-striatal LTD.
|
Restor Neurol Neurosci
|
2008
|
0.83
|
|
17
|
Oxcarbazepine in nocturnal frontal-lobe epilepsy: a further interesting report.
|
Pediatr Neurol
|
2008
|
0.79
|
|
18
|
NR2B-containing NMDA receptors promote the neurotoxic effects of 3-nitropropionic acid but not of rotenone in the striatum.
|
Exp Neurol
|
2006
|
0.76
|